Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Wearing-off Phenomenon of Ocrelizumab in Patients With Multiple Sclerosis

NCT04478591 is registered in ClinicalTrials.gov with Amsterdam UMC, location VUmc as lead sponsor.

NCT NCT04478591
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04478591 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Wearing-off Phenomenon of Ocrelizumab in Patients With Multiple Sclerosis
Lead sponsor
Amsterdam UMC, location VUmc
Phase
Observational
Overall status
Completed
Start date
May 12, 2020
Completion date
May 1, 2021
Enrollment
117 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis